« Previous AbstractHoneybee queen mandibular pheromone induces a starvation response in Drosophila melanogaster    Next Abstract"Effects of cleaning spray use on eyes, airways, and ergonomic load" »

Mil Med

Title:		Cancer Incidence and Etiology in the Active Duty Population of U.S. Military
Author(s):		Lovejoy LA; Shriver CD; Ellsworth RE;
Address:		"Clinical Breast Care Project, Chan Soon-Shiong Institute for Molecular Medicine at Windber, Windber, PA 15963, USA. Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20889, USA. Henry M. Jackson Foundation for the Advancement of Military Medicine, Windber, PA 15963, USA"
Journal Title:		Mil Med
Year:		2022
Volume:		20221014
Issue:
Page Number:		-
DOI:		10.1093/milmed/usac297
ISSN/ISBN:		1930-613X (Electronic) 0026-4075 (Linking)
Abstract:		"INTRODUCTION: As members of the military, all active duty service members (ADS) must meet physical fitness requirements and are provided with equal-access healthcare through the DoD. In addition, 92% of ADS are 800 ADS are diagnosed with cancer and the resulting in time off for treatment, reassignment, or medical retirement may significantly impact force readiness. MATERIAL AND METHODS: Relevant literature was identified by searching the PubMed database using search terms ACTIVE DUTY and CANCER. Only articles written in English were included. RESULTS: Melanoma is the most common cancer in ADS, while testicular cancer is the most common cancer in males and breast cancer is the most common in females. Cancer incidence patterns in ADS differ from those in the general U.S. population and from military veterans. Tumor etiology in ADS may be influenced by military-enriched exposures such as prolonged use of oral contraceptives, suboptimal use of sunscreen, exposure to volatile organic compounds, or germline predisposition/family history. CONCLUSIONS: The etiology of cancer within ADS remains largely unknown. A number of new research programs may provide the means to improve understanding of the etiology of cancer in ADS. Together, these efforts will improve prevention, early detection, and clinical management, thus improving the outcomes of ADS and preserving force readiness"
Keywords:
Notes:		"PublisherLovejoy, Leann A Shriver, Craig D Ellsworth, Rachel E eng HU0001-16-2-0004/Uniformed Services University of the Health Sciences/ England 2022/10/15 Mil Med. 2022 Oct 14:usac297. doi: 10.1093/milmed/usac297"